Skip to main content
. Author manuscript; available in PMC: 2021 Oct 15.
Published in final edited form as: Ophthalmology. 2016 Aug 29;123(10):2085–2092. doi: 10.1016/j.ophtha.2016.06.038

Table 4.

Change in intraocular pressure.

Change in IOP (mm Hg)
9:30 AM 10:30 AM 11:30 AM 12:30 PM 1:30 PM 2:30 PM 3:30 PM
Latanoprost Solution
Treatment Day 3 −5.4 ± 1.0
Day 5 −3.4 ± 0.3 −5.3 ± 0.5 −6.6 ± 1.3 −5.4 ± 1.0* −5.1 ± 1.4 −4.0 ± 0.6 −2.9 ± 1.0
Post-treatment Day 3 −0.6 ± 1.4
CLLO Treatment Day 3 −6.3 ± 1.0*
Day 5 −6.7 ± 0.3 § (n=3)
Day 8 −7.8 ± 3.8* −7.4 ± 3.4* −7.8 ± 3.0* −6.9 ± 1.3* −6.6 ± 2.1 −5.3 ± 1.7 −4.0 ± 1.1
Post-Treatment Day 1 −3.0 ± 3.4
Post-Treatment Day 3 −1.8 ± 3.9
CLHI Treatment Day 3 −10.5 ± 1.4**§
Day 5 −11.1 ± 4.0*§
Day 8 −10.0 ± 2.5* § (n = 3) −9.3 ± 4.2* (n=3) −8.8 ± 3.5** (n=3) −9.2 ± 3.2* (n=3) −10.2 ± 2.4*§ (n=3) −8.2 ± 2.3 *§ (n=3) −6.0 ± 4.4 (n=3)
Post-Treatment Day 1 −4.0 ± 3.1 (n=3)
Post-Treatment Day 3 −3.7 ± 4.0 (n=3)
Post-T reatment Day 8 −1.0 ± 1.3 (n=3)

Data are mean changes in Intraocular pressure (IOP) ± standard deviation from baseline

*

p<0.05

**

p<0.005 in comparison to baseline (2-tailed Student-test);

§

p<0.05 in comparison to latanoprost drop treatment at the same time, using Student t-test. Changes in IOP for the CLHI on Day 8 were compared to the last day of treatment (Day 5) with latanoprost drops. CLLO = Low-dose contact lens. CLHI = High-dose CL; n = 4 unless otherwise noted.